Results 71 to 80 of about 43,130 (164)

Targeting Peptidergic Systems for Melanoma Treatment. [PDF]

Cancers (Basel)
Sánchez ML, Mehboob R, Coveñas R.
europepmc   +1 more source

A real-world retrospective study of vitiligo associated with immune checkpoint inhibitors based on FAERS and TCGA databases. [PDF]

Medicine (Baltimore)
Ma J, Cai Z, Luo Y, Li X, Li J, Hou M, Zhu D.   +6 more
europepmc   +1 more source

The hair: Melanocyte nexus

International Journal of Trichology, 2013
openaire   +3 more sources

Early Proteomic Alterations in Non-segmental Vitiligo Skin Following Treatment with Topical Tacrolimus. [PDF]

Dermatol Ther (Heidelb)
Haulrig MB, Kabatnik S, Skov L, Løvendorf MB, Dyring-Andersen B.   +4 more
europepmc   +1 more source

Circadian Clock Regulates Epidermal Endocrine System in Homeostatic Skin Pigmentation. [PDF]

Exp Dermatol
Zhu A, Yang L, Lai S, Yang F, Tsuruta D, Katayama I.   +5 more
europepmc   +1 more source

The role of JAK3 and TEC family kinases in vitiligo pathogenesis. [PDF]

Front Immunol
Passeron T, Seneschal J, Picardo M, Xiang L, Tanemura A, Winkler A, Telliez JB, Adiri R.   +7 more
europepmc   +1 more source

Genotype-Encoded UV Sensitivity in iPSC-Derived Human Melanocytes Reveals MX2 as a Physiological Amplifier of p53/p38-Mediated DNA Damage Signaling. [PDF]

Int J Mol Sci
Ramirez-Salazar E, Slipicevic A, Juraleviciute M, Li L, Harland M, O'Shea S, Field S, Newton-Bishop J, Herlyn M.   +8 more
europepmc   +1 more source

Beyond the boundaries of pigmentation and inflammation: understanding the mechanistic basis of melasma-rosacea comorbidity. [PDF]

Front Med (Lausanne)
Li X, Shi H, Feng Y.
europepmc   +1 more source

Genetics of Vitiligo: A Review. [PDF]

Clin Cosmet Investig Dermatol
He H, Su R, Liu F.
europepmc   +1 more source

The Cutaneous Immune Microenvironment in Selected Inflammatory Skin Diseases: Linking Histopathology, Mechanisms, and Targeted Therapy. [PDF]

Dermatopathology (Basel)
Tinca AC, Cozac-Szoke AR, Cotoi OS.
europepmc   +1 more source